{
    "symbol": "AVIR",
    "quarter": 4,
    "year": 2022,
    "date": "2023-02-28 22:14:09",
    "content": " Also, at day 3, 100% of patients who presented with baseline body temperature above 37 degrees Celsius had a reduction in body temperature below that baseline levels in the AT-752 arm versus only 33% of patients in the placebo arm. Turning to slide 20 The human infection challenge study was also a randomized, double blind placebo control trying evaluating AT-752 dose of 750 milligram TID where dosing was initiated prophylactically 24 hours ahead of subject receiving an injection of attenuated live Dengue 1 Virus."
}